SEC Form 4 · accession 0001213900-16-010536
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Brooks
Officer — SVP of Business Development
Period of report
Feb 1, 2016
Accepted (ET)
Feb 2, 2016 · 11:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.32 | Feb 1, 2016 | A | 300,000 | A | — | Dec 4, 2018 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The stock option vests in increments upon the attainment of certain operational and financial milestones of the Issuer.